Niu, T
2744  results:
Search for persons X
?
1

Solute synergy induced thermal stability of high-strength n..:

Richter, N.A. ; Zhang, Y.F. ; Gong, M....
Materials Science and Engineering: A.  862 (2023)  - p. 144477 , 2023
 
?
2

PRECLINICAL AND A PHASE 1 STUDY OF PURINOSTAT MESYLATE, A N..:

Wang, J. ; Yang, L. ; Qiu, Q....
Hematological Oncology.  41 (2023)  S2 - p. 806-808 , 2023
 
?
3

A PREDICTIVE MODEL FOR ULTRA‐HIGH RISK IN PATIENTS WITH NEW..:

Zhang, L. ; Zou, R. ; Tang, W....
Hematological Oncology.  41 (2023)  S2 - p. 777-777 , 2023
 
?
4

A REAL‐WORLD STUDY OF CHIDAMIDE FOR PATIENTS WITH PERIPHERA..:

Wang, X. ; Zhao, A. ; Niu, T.
Hematological Oncology.  41 (2023)  S2 - p. 766-766 , 2023
 
?
5

Beaklike ossification in ankylosing spondylitis:

Liu, S ; Niu, T ; Wang, Y
QJM: An International Journal of Medicine.  116 (2023)  11 - p. 949-949 , 2023
 
?
6

MA18.11 A Phase Ib/II Study of Senaparib in Combination wit..:

Hong, M.H. ; Gao, B. ; Cheng, Y....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S169-S170 , 2023
 
?
7

Unraveling the size fluctuation and shrinkage of nanovoids ..:

Nasim, M. ; Rayaprolu, Sreekar ; Niu, T....
Journal of Nuclear Materials.  574 (2023)  - p. 154189 , 2023
 
?
8

A POPULATION‐BASED STUDY REVEALS THE UNIQUE CLINICAL CHARAC..:

Wang, X. ; Zhao, A. ; Niu, T.
Hematological Oncology.  41 (2023)  S2 - p. 706-706 , 2023
 
?
9

A NOVEL CONDITIONING REGIMEN OF CHIDAMIDE, CLADRIBINE, GEMC..:

Zeng, Q. ; Zhang, H. ; Kuang, P....
Hematological Oncology.  41 (2023)  S2 - p. 765-766 , 2023
 
?
10

EFFICACY OF FRONT‐LINE IMMUNOCHEMOTHERAPY FOR TRANSPLANT‐IN..:

Jing, C. ; Zhao, A. ; Wang, J..
Hematological Oncology.  41 (2023)  S2 - p. 760-761 , 2023
 
?
11

TARGETED AGENTS COMBINED WITH CHOP COMPARED WITH CHOP AS TH..:

Cai, M. ; Cheng, S. ; Jing, H....
Hematological Oncology.  41 (2023)  S2 - p. 78-79 , 2023
 
?
12

Micromechanical properties and microstructures of AC and DC..:

Shen, Chao ; Niu, T. ; Yang, Bo...
Materials Science and Engineering: A.  866 (2023)  - p. 144631 , 2023
 
?
13

ACTIVITY AND SAFETY OF PRECLINICAL AND A PHASE 1 STUDY OF P..:

Wang, J. ; Yang, L. ; Lin, X....
Hematological Oncology.  41 (2023)  S2 - p. 804-806 , 2023
 
?
 
?
15

Efficacy and safety of Axicabtagene ciloleucel (Axi‐cel) fo..:

Zhao, W. L. ; Li, Y. H. ; Zou, D. H....
Hematological Oncology.  41 (2023)  S2 - p. 457-458 , 2023
 
1-15